GZMB and breast cancer: GRα and β isoforms have important roles with opposite functions, hence we assessed the expression of the GR using an N-terminal specific antibody referred to as GRtotal, and a selective antibody specific against the GRβ isoform (GRβ) on an independent sample cohort of 9 TNBC and 11 luminal A type (ER+, PR+, negative for HER2) breast cancer tissues (see primary staining and negative controls omitting the primary antibody in Supplementary Figure S1, which also indicates the specificity of cytoplasmic localization).